Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1077130

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people with serious fatigue syndrome in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	225514
answer	answer is ministerial correction date of answer 05/03/2019 answer text <p>No estimate has been made. Departmental officials do not recognise the diagnosis term “serious fatigue syndrome”.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2019 17:12:46 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

1077132

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his policy paper Tackling antimicrobial resistance 2019 to 2024: the UK's 5-year national action plan, whether he has made an assessment of the effect of the UK’s childhood vaccination programme on levels of anti-microbial resistance in the UK; and if he will make a statement.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	225531
answer	answer is ministerial correction date of answer 05/03/2019 answer text <p>‘Tackling antimicrobial resistance (2019-24): The UK’s five-year national action plan’, recognises that immunisation is one of the most effective public health interventions to prevent infection in humans and animals.</p><p> </p><p>Vaccination programmes have been successful and cost-effective in helping avert millions of cases of childhood illness, with large reductions in cases of serious infections. By reducing the burden of infection, vaccine programmes play an important role in reducing levels of antibiotic prescribing and therefore the selective pressure for the emergence and spread of antibiotic resistance.</p><p> </p><p>The childhood pneumococcal vaccine programme has led to declines in some antibiotic resistant clones of pneumococcus that are covered by the PCV13 vaccine. Also, the influenza vaccination programme helps to reduce the use of and requirement for antibiotics by reducing cases of respiratory illness and of secondary bacterial pneumonia.</p><p> </p><p>In addition, the new Joint Committee on Vaccination and Immunisation (JCVI) Healthcare Associated Infections Working Group, set up to review and provide preliminary advice to JCVI on the potential use of appropriate vaccines in the United Kingdom, will help to address this issue.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2019 17:19:23 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

1077133

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of adequacy of the number of trained radiologists.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	225532
answer	answer is ministerial correction date of answer 05/03/2019 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017 which commits to the expansion of capacity and skills including an ambition to increase improved working practices, attracting qualified people back to the National Health Service through domestic and international recruitment. This will include 668 more, full time equivalent, clinical radiologists and investing in 300 reporting radiographers by 2021 to support an increase in the capacity for earlier diagnosis.</p><p>Following publication of the NHS Long Term Plan in January 2019, my Rt. hon. Friend the Secretary of State for Health and Social Care has commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including staff working on cancer, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2019 17:15:58 answering member 4067 label Biography information for Steve Brine
tabling member	4382 label Biography information for Daniel Zeichner

1077148

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the 2019 Voluntary scheme for branded medicines pricing and access, what plans NHS England has to consult patient organisations on the new commercial framework which is being developed.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	225602
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>NHS England, together with the National Institute for Health and Care Excellence, is developing a ’commercial framework’ setting out the parameters for the commercial approach for medicines in the health service in England. This framework will be tested with and informed through consultation with stakeholders. In preparation for public consultation in the coming months, NHS England is actively engaging with industry trade bodies and health system partners, in the first instance, to progress the development of the commercial framework, as set out in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2019 16:23:38 answering member 4067 label Biography information for Steve Brine
tabling member	4610 label Biography information for Bambos Charalambous

1077183

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	22q11.2 Deletion Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect on the public purse of adding a test for 22q11 deletion syndrome to the newborn blood spot test.
tabling member constituency	Banff and Buchan
tabling member printed	David Duguid
uin	225599
answer	answer is ministerial correction date of answer 06/03/2019 answer text <p>No assessment has been made on adding a test for 22q11 deletion syndrome to the newborn blood spot test as the United Kingdom National Screening Committee’s (UK NSC) had not previously been asked to look at this condition.</p><p> </p><p>However, as part of the UK NSC`s annual call for topics 2018, a proposal was received to consider adding the condition of 22q11 deletion syndrome (also known as DiGeorge syndrome) to the new born blood spot programme.</p><p> </p><p>This is the first time the UK NSC has been asked to consider screening for 22q11. The UK NSC will be reviewing the proposal at its meeting at the end of the month and to agree next steps. Minutes of the meeting will then be published six weeks after and be made available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc" target="_blank">https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 225600 question first answered 06/03/2019 16:41:39 answering member 4067 label Biography information for Steve Brine
tabling member	4606 label Biography information for David Duguid

1077184

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	22q11.2 Deletion Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department’s policy is on adding a test for 22q11 deletion syndrome to the newborn blood spot test.
tabling member constituency	Banff and Buchan
tabling member printed	David Duguid
uin	225600
answer	answer is ministerial correction date of answer 06/03/2019 answer text <p>No assessment has been made on adding a test for 22q11 deletion syndrome to the newborn blood spot test as the United Kingdom National Screening Committee’s (UK NSC) had not previously been asked to look at this condition.</p><p> </p><p>However, as part of the UK NSC`s annual call for topics 2018, a proposal was received to consider adding the condition of 22q11 deletion syndrome (also known as DiGeorge syndrome) to the new born blood spot programme.</p><p> </p><p>This is the first time the UK NSC has been asked to consider screening for 22q11. The UK NSC will be reviewing the proposal at its meeting at the end of the month and to agree next steps. Minutes of the meeting will then be published six weeks after and be made available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc" target="_blank">https://www.gov.uk/government/groups/uk-national-screening-committee-uk-nsc</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 225599 question first answered 06/03/2019 16:41:39 answering member 4067 label Biography information for Steve Brine
tabling member	4606 label Biography information for David Duguid

1077199

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Insurance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to bring forward legislative proposal for a state-backed indemnity scheme for health care professionals.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	225395
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>The National Health Service (Clinical Negligence Scheme for General Practice) Regulations 2019 were laid in parliament on 25 February 2019 and come into force on 1 April 2019. The Regulations establish a scheme which provides indemnity cover for future clinical negligence liabilities of general practitioners, and others working in general practice in respect of services provided as part of the National Health Service in England.</p><p> </p><p>The Department also intends to establish the arrangements for an existing liabilities scheme in April 2019, subject to satisfactory discussions with the Medical Defence Organisations.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2019 16:22:50 answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1077200

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	UK Antimicrobial Resistance Diagnostics Collaborative
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 February 2019 to Question 219373 on UK Antimicrobial Resistance Diagnostics Collaborative, what representations his Department has received from members of that Collaborative; if he will publish the names of its members; and whether a Chair of that Collaborative has been appointed.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	225396
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>NHS England established the United Kingdom Antimicrobial Resistance (AMR) Diagnostics Collaborative in 2018 to deliver the UK’s diagnostic ambitions for AMR. The Collaborative has played a valuable role in developing the diagnostic elements of the new five-year UK AMR national action plan, published in January this year.</p><p> </p><p>The work of the Collaborative contributes directly to the Government’s commitments on AMR, and the Collaborative’s secretariat communicates with the Department on a regular basis and it has been represented by its secretariat and former chair in the UK AMR Programme’s governance groups.</p><p> </p><p>The Collaborative’s chair remains vacant while NHS England develops detailed plans to support the implementation of the new national plan on AMR. As part of this work, the membership of the Collaborative is under review.</p><p> </p><p>Current membership is drawn from a range of stakeholders across Government and its agencies, the devolved administrations, the health system, veterinary medicine, professional bodies, academia, the research community and industry. Members at or above ‘very senior manager’ (VSM) level and partner agencies involved in the Collaborative are listed in the following table.</p><table><tbody><tr><td><p>Members of the UK Antimicrobial Resistance Diagnostics Collaborative at or above VSM level</p></td><td><p>Organisation</p></td></tr><tr><td><p>Mohamed Sadak</p></td><td><p>Health Education England</p></td></tr><tr><td><p>Marion Lyons</p></td><td><p>Welsh Government</p></td></tr><tr><td><p>Gerry Waldron</p></td><td><p>Public Health Agency Northern Ireland</p></td></tr><tr><td><p>Neil Woodford</p></td><td><p>Public Health England</p></td></tr><tr><td colspan="2"><p>Partner Agencies</p></td></tr><tr><td><p>NHS Scotland</p></td><td><p>NHS England</p></td></tr><tr><td><p>NHS Sheffield Clinical Commissioning Group</p></td><td><p>Department of Health and Social Care</p></td></tr><tr><td><p>NHS Improvement</p></td><td><p>University of Bristol</p></td></tr><tr><td><p>Institute of Biomedical Science</p></td><td><p>Association of Clinical Biochemistry and Laboratory Medicine</p></td></tr><tr><td><p>UK Standards for Microbiology Investigations</p></td><td><p>Royal College of Pathology</p></td></tr><tr><td><p>Royal College of General Practice</p></td><td><p>National Institute for Health and Care Excellence (NICE) Medical Technology Guidance</p></td></tr><tr><td><p>Sherwood Forrest NHS Foundation Trust</p></td><td><p>Royal College of Nursing</p></td></tr><tr><td><p>University of Surrey</p></td><td><p>Addenbrookes Hospital NHS Trust</p></td></tr><tr><td><p>University of Edinburgh</p></td><td><p>Medical Research Council</p></td></tr><tr><td><p>British In Vitro Diagnostic Association</p></td><td><p>NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative</p></td></tr><tr><td><p>Innovate UK</p></td><td><p>NICE</p></td></tr><tr><td><p>Royal Cornwall Hospital</p></td><td><p>Kingston University</p></td></tr><tr><td><p>Department for Environment, Food and Rural Affairs</p></td><td><p>Responsible Use of Medicines in Agriculture Alliance</p></td></tr><tr><td><p>University of Liverpool</p></td><td><p>Ulster University</p></td></tr><tr><td><p>University of Exeter</p></td><td><p>Westpoint Farm Vets</p></td></tr><tr><td><p>University of Nottingham</p></td><td><p>Centre for Ecology and Hydrology</p></td></tr><tr><td><p>Cardiff University</p></td><td><p>Guy’s and St Thomas’ Hospital NHS Foundation Trust</p></td></tr><tr><td><p>Glasgow Caledonian University</p></td><td><p> </p></td></tr></tbody></table> answering member constituency Winchester answering member printed Steve Brine question first answered 21/03/2019 16:10:43 answering member 4067 label Biography information for Steve Brine previous answer version 105072 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	392 label Biography information for Sir Kevin Barron

1077256

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Food: Packaging
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department’s policy is on food companies that fail to disclose allergens on their packaging.
tabling member constituency	Upper Bann
tabling member printed	David Simpson
uin	225468
answer	answer is ministerial correction date of answer 05/03/2019 answer text <p>Food businesses are required to declare allergenic ingredients on the packaging of pre-packed foods. For foods pre-packed for direct sale, there is also a legal requirement to provide allergen information but, given the nature of the business, there is an option to provide this orally on consumer request. In cases where food companies fail to disclose allergens, the Food Standards Agency may issue an allergy alert and companies will be required to withdraw or recall the affected product. The local authority should follow up with the business but failure of a business to comply with the relevant legal requirements may ultimately result in criminal prosecution.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2019 17:12:02 answering member 4067 label Biography information for Steve Brine
tabling member	1597 label Biography information for David Simpson

1077274

registered interest
date	25/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Obstructive Pulmonary Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the (a) diagnosis of (b) and treatment for chronic obstructive pulmonary disease.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	225451
answer	answer is ministerial correction date of answer 05/03/2019 answer text <p>Respiratory disease is a clinical priority within the recently published NHS Long Term Plan. This has the overarching objective of improving outcomes for people with respiratory disease. The NHS Long Term Plan sets out how the NHS will take action in a number of areas, including expanding programmes that support earlier diagnosis of chronic obstructive pulmonary disease (COPD), and increasing access to treatments.</p><p> </p><p>From 2019, the National Health Service will build on the existing NHS RightCare programme to reduce variation in the quality of spirometry testing (one of the tests used to diagnose COPD).</p><p> </p><p>The NHS is also planning to roll out the lung health check programme, which targets those most at risk of cancer. Based on the pioneering schemes in Manchester and Liverpool, the lung health check will not just identify more cancers quickly, but will also pick up cases of COPD.</p><p> </p><p>The NHS Long Term Plan also sets out the NHS’ ambition to improve access to treatments for COPD. Over the next 10 years access to pulmonary rehabilitation will be expanded.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/03/2019 17:20:41 answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper